Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Pistoia Alliance
Pistoia Alliance
Activities:
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Regulatory
Animal testing still being 'unnecessarily' utilised by a majority of R&D organisations, survey reveals
Although there are in vitro alternatives that could more accurately predict human therapeutic responses, a majority of R&D companies still use animal testing
Regulatory
Pistoia Alliance survey reveals lack of understanding in laws regulating AI
Survey exposes knowledge gap surrounding AI legislation, with a fifth of respondents confirming regulations are blocking their research
The Pistoia Alliance announces new priorities to accelerate sustainability, AI, and FAIR data in R&D
Member-led steering committees composed of global pharma and tech representatives will develop new project ideas to drive industry change
Manufacturing
GSK and Pistoia Alliance announce laboratory tech to improve reproducibility
Founded by Pistoia Alliance and now implemented at GSK, the Methods Hub is a digital tool that enables the instant transfer and overlaying of analytical methods
Regulatory
Pistoia Alliance launches Women in STEM leadership pilot
15 companies are involved in the pilot stage, including AstraZeneca, GlaxoSmithKline and Merck KGaA
Research & Development
Pistoia Alliance predicts surge in life science quantum computing research
The not-for-profit also suggests the new year will see a "renewed focus" on the fight against antimicrobial resistance
Research & Development
Survey shows life sciences professionals lack quantum computing understanding
The survey, done by The Pistoia Alliance, also highlighted more than a third (36%) of respondents believe QC will impact the biopharma industry within the next five years
Subscribe now